Article Per Year (5 Year)
p-Index From 2020 - 2025
0
P-Index
This Author published in this journals
All Journal Jurnal Farmasi Galenika (Galenika Journal of Pharmacy)
Senfri Tandililing
Universitas Tadulako
Biochemistry, Genetics & Molecular Biology Chemistry Health Professions Immunology & microbiology Medicine & Pharmacology

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Profil Penggunaan Obat Pasien Hipertensi Esensial Di Instalasi Rawat Jalan Rumah Sakit Umum Daerah I Lagaligo Kabupaten Luwu Timur Periode Januari-Desember Tahun 2014: Profile of Drug Use In Patients With Essential Hypertension at Outpatient Installation General Hospital I Lagaligo Luwu Timur Regency Period of January-December 2014 Senfri Tandililing; Alwiyah Mukaddas; Ingrid Faustine
Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (e-Journal) Vol. 3 No. 1 (2017): (March 2017)
Publisher : Universitas Tadulako

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (280.57 KB) | DOI: 10.22487/j24428744.2017.v3.i1.8139

Abstract

This study aimed to determine the demographic and clinical characteristics and profile of drug use in patients with essential hypertension at outpatient installations I Lagaligo General Hospital East Luwu Regency period January-December 2014. The research method is descriptive done retrospectively by collecting secondary data from medical records essential hypertension patients undergoing outpatient treatment at General Hospital I Lagaligo East Luwu Regency period January-December 2014. The number of samples in the study were 145 patients. The dominant demographic characteristics of women that 87 patients (60%), age range 41-60 years (55.86%), hypertension grade 1 (73.78%), a class of drugs most widely used is a calcium antagonist (45.45%), the type of drug amlodipine (44.27%), 100% tablet dosage forms, rules of use 1 to 2 times a day, namely amlodipine monotherapy (63.08%), the combination of two antihypertensive amlodipine-hydrochlorothiazide (38.61%), the combination of three antihypertensive amlodipine-hydrochlorothiazide-Captopril (69.57%). The results obtained in accordance with an algorithm treatment of hypertension according to Joint National Committee (JNC 7).
Co-Authors Alwiyah Mukaddas Ingrid Faustine